Published in AIDS Weekly, May 13th, 1996
"The message is, don't do this on your own. Wait till more data's available," Daniel Berman, Hoffmann-LaRoche, Nutley, New Jersey, said. Saquinavir and ritonavir are part of a class of drugs that inhibit protease, an enzyme needed in the reproduction of HIV.
Hoffmann-LaRoche makes Invirase, the brand name for saquinavir, which was approved for sale by the U.S. Food and Drug Administration (FDA) in December 1995. The other drug, sold as Norvir, was approved...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.